Aquamor announce strategic global collaboration agreement with Europharma AS
Agreement covers various technologies for the Salmon industry
Stockton STK specializes in the development and marketing of botanical based biopesticides, and Europharma AS develops, produces, packages, and distributes pharmaceuticals and fish feeds, today announced that the companies have entered a Global Exclusive development and distribution agreement of the Aquamor products’ family. The agreement covers various botanical based solutions for the Salmons industry.
The partnership is intended to leverage both companies’ strengths, and innovative capabilities in the development, manufacturing and distribution of a combined new sustainable products, based on the existing technologies. The two companies plan to join their research and development activities, in manufacturing antibacterial feed additive
Under the terms of the agreement, the product will be manufactured and supplied by Aquamor and Europharma AS, headquarter in Leknes, Norway, will distribution and sell under Aquamor brands. Aquamor will continue to manage all product registrations.
“We are excited to have open a strategic distribution agreement with Europharma AS,” explain Guy Elitzur, CEO of Stockton STK. “The Company is well established in the geographical regions where Aquamor products are in high demand, allowing aquaculture producers easier access to purchase our innovative sustainable solutions to meet those challenges fish farmers face today in vaccination, transportation and stress reduction. We believe that our technologies will have a significant impact in the Aquaculture industry.”
The aquaculture is a fastest-growing sector in animal protein production with an overall estimated market value of 50 million tons production by 2030, to meet global demand. Aquamor products reduce mortality in fish, shrimp and other aquatic organisms. The products are based on innovative formulations of organic compounds extracted from plants, which have been extensively tested and proven in clinical and field tests.
“STK Aquamor has developed products that we believe can be uniquely beneficial to the aquaculture industry. We look forward to doing our part in making these products available on the global market” confirms Jim Roger Nordly, Owner and CEO of Europharma AS.
About Europharma AS
Europharma AS And its sister companies develops, produces, packages, and distributes fish health related products, including pharmaceuticals and fish feeds. The company was founded in 1995 and is based in Leknes, Norway, with subsidiaries in Chile, Canada and Scotland. Europharma AS operates as a subsidiary of Nordly Holding AS.
For more information, please visit: http://europharma.no/
Aquamor, the Veterinary Unit of the STK Stockton, develops and commercializes products based on its proprietary, patented intellectual properties for the growing aquaculture industry. Aquamor provides cost-effective solutions to reduce mortality of fish, shrimp and other aquatic organisms.
STK Stockton currently operates in more than 25 countries worldwide. STK Stockton’s Research and Development Innovation Center is devoted to catering to the complex challenges facing modern sustainable aquaculture, and to meet today’s global food consumer markets’ demands.